TWO SIGMA ADVISERS, LP - ELOXX PHARMACEUTICALS INC ownership

ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 33 filers reported holding ELOXX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$13,000
-90.1%
49,300
-78.9%
0.00%
Q1 2022$131,000
-60.4%
233,400
-50.1%
0.00%
-100.0%
Q4 2021$331,000
-71.2%
468,000
-33.6%
0.00%
-66.7%
Q3 2021$1,150,000
+157.3%
705,300
+214.2%
0.00%
+200.0%
Q2 2021$447,000224,5000.00%
Other shareholders
ELOXX PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 375,000$3,739,0001.40%
CVI Holdings, LLC 223,140$2,226,0000.86%
MENORA MIVTACHIM HOLDINGS LTD. 2,202,456$21,958,0000.59%
Ion Asset Management Ltd. 225,000$2,243,0000.57%
Altshuler Shaham Ltd 1,093,859$11,343,0000.48%
MEITAV INVESTMENT HOUSE LTD 500,436$4,987,0000.33%
Clal Insurance Enterprises Holdings Ltd 595,000$5,932,0000.14%
New England Private Wealth Advisors LLC 50,000$499,0000.12%
EMERALD MUTUAL FUND ADVISERS TRUST 200,000$1,994,0000.08%
ING GROEP NV 30,000$299,0000.01%
View complete list of ELOXX PHARMACEUTICALS INC shareholders